The goal of APDS is to maintain stable and optimal blood glucose levels throughout the day, reducing the risk of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) and improving overall diabetes management. APDS offers benefits such as better glycemic control, reduced dependence on manual insulin administration, fewer fluctuations in blood glucose levels, and improved quality of life for individuals with diabetes.
Request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/1406
The artificial pancreas device systems market can be segmented based on various factors. Here are some common segmentation approaches:
By Type of Control Algorithm:
Threshold Suspend Systems: These systems temporarily suspend insulin delivery when glucose levels fall below a certain threshold to prevent hypoglycemia.
Predictive Low Glucose Suspend Systems: These systems proactively reduce or suspend insulin delivery when low glucose levels are predicted.
Control-to-Range Systems: These systems aim to maintain glucose levels within a target range by adjusting insulin delivery based on real-time glucose measurements.
Control-to-Target Systems: These systems target a specific glucose level and adjust insulin delivery accordingly.
By Component:
Continuous Glucose Monitoring (CGM) Systems: This segment includes the sensors and transmitters that measure glucose levels.
Insulin Infusion Pumps: This segment includes the devices responsible for delivering insulin into the body.
Control Algorithms: This segment covers the software or algorithms that calculate and adjust the insulin delivery based on glucose measurements.
By End User:
Hospitals and Clinics: These include healthcare facilities where artificial pancreas device systems are used for inpatient and outpatient management of diabetes.
Home Care Settings: This segment includes individuals who use artificial pancreas device systems for self-management of diabetes in the comfort of their homes.
By Geography:
North America: This segment includes the United States and Canada.
Europe: This segment includes countries in the European region.
Asia Pacific: This segment includes countries in the Asia Pacific region, such as China, Japan, India, and Australia.
Latin America: This segment includes countries in Latin America, such as Brazil and Mexico.
Middle East and Africa: This segment includes countries in the Middle Eastern and African regions.
By Age Group:
Pediatric Population: This segment focuses on artificial pancreas device systems designed specifically for children and adolescents with diabetes.
Adult Population: This segment includes artificial pancreas device systems for adults with diabetes.
Key players in the artificial pancreas device systems market include:
- Defymed SAS
- TypeZero Technologies, Inc.
- Insulet Corporation
- Bigfoot Biomedical, Inc.
- Medtronic Plc
- Dexcom, Inc.
- Admetsys Corp.
- Beta Bionics, Inc.
- Cellnovo Group SA
- Tandem Diabetes Care, Inc.
Download pdf brochure: https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/1406
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Related report:
- Artificial Intelligence in Supply Chain Market
- Artificial Intelligence in Retail Market
- Artificial Turf Market
To know more
Contact Us:
Sales
Prophecy Market Insights
📞+1 860 531 2574
✉ Email– sales@prophecymarketinsights.com
🌐 Website- www.prophecymarketinsights.com
🌐 Blog- www.prophecyjournals.com
Follow us on: